These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8579097)

  • 1. The Golgi apparatus and the pathogenesis of Alzheimer's disease.
    Dal Canto MC
    Am J Pathol; 1996 Feb; 148(2):355-60. PubMed ID: 8579097
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P; Mufson EJ; Morán MA
    Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease. Tangle disentanglement.
    Beyreuther K; Masters CL
    Nature; 1996 Oct; 383(6600):476-7. PubMed ID: 8849716
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
    Beckman M
    Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
    [No Abstract]   [Full Text] [Related]  

  • 6. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I; Bernstein HG; Riederer P; Braunewell KH
    Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Alzheimer's disease and dementia.
    Bugiani O
    Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 13. Aluminium in Alzheimer's?
    Good PF; Perl DP
    Nature; 1993 Apr; 362(6419):418. PubMed ID: 8464473
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
    Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
    Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ; Sjögren M; Winblad B
    Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyloid protein--cause or effect of Alzheimer's disease].
    Leszek J
    Postepy Hig Med Dosw; 1994; 48(1):1-18. PubMed ID: 8058577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M; Spillantini MG; Hasegawa M; Jakes R; Crowther RA; Klug A
    Cold Spring Harb Symp Quant Biol; 1996; 61():565-73. PubMed ID: 9246483
    [No Abstract]   [Full Text] [Related]  

  • 18. Tau phosphorylation in Alzheimer's disease: pathogen or protector?
    Lee HG; Perry G; Moreira PI; Garrett MR; Liu Q; Zhu X; Takeda A; Nunomura A; Smith MA
    Trends Mol Med; 2005 Apr; 11(4):164-9. PubMed ID: 15823754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amyloid cascade hypothesis.
    Korczyn AD
    Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.